In the U.S., Hispanic women have been disproportionately affected by the HIV epidemic in recent years. Yet they’ve been less likely to take advantage of PrEP, a medication that significantly reduces the risk of getting HIV.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
